FR2454808A1 - Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity - Google Patents

Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity

Info

Publication number
FR2454808A1
FR2454808A1 FR7910652A FR7910652A FR2454808A1 FR 2454808 A1 FR2454808 A1 FR 2454808A1 FR 7910652 A FR7910652 A FR 7910652A FR 7910652 A FR7910652 A FR 7910652A FR 2454808 A1 FR2454808 A1 FR 2454808A1
Authority
FR
France
Prior art keywords
cerebral
syn
eburnane
homo
oxime
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7910652A
Other languages
French (fr)
Other versions
FR2454808B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7910652A priority Critical patent/FR2454808A1/en
Publication of FR2454808A1 publication Critical patent/FR2454808A1/en
Application granted granted Critical
Publication of FR2454808B1 publication Critical patent/FR2454808B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Syn and anti forms of E-homo eburnane oximes of formula (I) and their acid addn. salts are new. A mixt. of syn and anti forms of (I) is disclosed in FR 2104959. Their sepn. may be effected by chromatography. Cerebral vasoregulators useful in the treatment of cerebral vasculopathies, and all other disorders caused by change in cerebral circulation. They allow the prevention or treatment of cerebral arteriosclerosis, meningeal or cerebral haemorrages, cerebral insufficiency, cerebro-vascular accidents and cranial trauma.
FR7910652A 1979-04-26 1979-04-26 Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity Granted FR2454808A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7910652A FR2454808A1 (en) 1979-04-26 1979-04-26 Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7910652A FR2454808A1 (en) 1979-04-26 1979-04-26 Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity

Publications (2)

Publication Number Publication Date
FR2454808A1 true FR2454808A1 (en) 1980-11-21
FR2454808B1 FR2454808B1 (en) 1983-02-18

Family

ID=9224795

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7910652A Granted FR2454808A1 (en) 1979-04-26 1979-04-26 Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity

Country Status (1)

Country Link
FR (1) FR2454808A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529551A1 (en) * 1982-06-30 1984-01-06 Richter Gedeon Vegyeszet EBURNANE-OXIME DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US4549020A (en) * 1982-06-30 1985-10-22 Richter Gedeon Vegyeszeti Gyar Rt. Eburnane oxime ethers
US4551462A (en) * 1982-06-30 1985-11-05 Richter Gedeon Vegyeszeti Gyar Rt. Eburnane derivatives, process for their preparation and pharmaceutical compositions containing them

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2104959A2 (en) * 1970-09-10 1972-04-28 Roussel Uclaf Vincamine process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2104959A2 (en) * 1970-09-10 1972-04-28 Roussel Uclaf Vincamine process

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529551A1 (en) * 1982-06-30 1984-01-06 Richter Gedeon Vegyeszet EBURNANE-OXIME DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US4549020A (en) * 1982-06-30 1985-10-22 Richter Gedeon Vegyeszeti Gyar Rt. Eburnane oxime ethers
US4551462A (en) * 1982-06-30 1985-11-05 Richter Gedeon Vegyeszeti Gyar Rt. Eburnane derivatives, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FR2454808B1 (en) 1983-02-18

Similar Documents

Publication Publication Date Title
DE68929540T2 (en) Substituted phenylpyrimidines derivatives, for the treatment or prevention of CNS disorders
EP0065542A4 (en) Compounds suitable for treatment or prophylaxis of cardiac disorders.
CA2203836A1 (en) Use of astaxanthin for retarding and ameliorating central nervous system and eye damage
IL55227A (en) Pharmaceutical compositions comprising(all-z)-5,8,11,14,17-eicosapentaenoic acid or its salts,esters or amides for the treatment and prophylaxis of thromboembolic conditions
NZ225274A (en) Methylene phosphonoalkylphosphinic acid derivatives and pharmaceutical compositions
PH17666A (en) Non-yellowing topical pharmaceutical composition
FR2454808A1 (en) Syn. and anti E homo eburnane oxime - having cerebral circulation regulating activity
EP0065964A4 (en) Method for treatment or prophylaxis of cardiac disorders.
AU7896781A (en) Method for treatment or prophylaxis of cardiac disorders
EP0383171A3 (en) 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders
ZA817931B (en) Compounds and method for treatment or prophylaxis of cardiac disorders
ES8702910A1 (en) Benzodiazepines, process for their preparation and their use.
ES8502103A1 (en) Substituted piperazin-1-yl-acetic-acid amides, process for their preparation and their use.
Matussek Clinical and animal experiments concerning the function of brain catecholamines.
Weiler et al. Auditory adaptation: Loudness balancing vs midplane localization.
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
Yaryura-Tobias et al. Psychosis and disturbance of glucose metabolism.
Doongaji et al. Pimozide versus chlordiazepoxide in anxiety neurosis.
SU1169672A1 (en) Method of treatment of disturbances of postural equilibrium
Rupert et al. Effects of bidirectional heart rate biofeedback training on the heart rates and anxiety levels of anxious psychiatric patients.
Oftedal Scandinavian EEG Society: Steroid treatment of infantile spasms with hypsarrhythmia.
Zielinski et al. Pavlovian trace conditioning and inhibition of fear in shuttlebox-avoidance behavior
Van Mierlo Open pilot trial of pimozide in patients suffering from psychic stress.
DE3172729D1 (en) Method for treatment or prophylaxis of cardiac disorders
Podivinský et al. Effect of vestibular caloric stimulation of the H-reflex in hemiparetic patients with focal ischemia of the brain.

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
TP Transmission of property